Ulteriori informazioni
Most symposia on chronic inflammatory bowel disease during the last few years have focused on new aspects of aetiology and pathophysiology. However, based on such new aspects, changes in diagnosis and treatment have been developed over the last few years and some others are currently under investigation.
This book, the proceedings of Falk Symposium 97, `Clinical Challenges in Inflammatory Bowel Diseases - Diagnosis, Prognosis and Treatment', held in Lugano, Switzerland, 18-19 April 1997, summarizes these changes and new developments, discusses their value and defines further new approaches. The topics include primary diagnosis, definition of different patient groups, special problems of these patients in daily life and very new therapeutic principles.
This volume opens new possibilities of diagnosis and treatment of inflammatory bowel disease to physicians and provides stimulation for further development.
Sommario
Preface. Section I: Aetiology and Pathophysiology. 1. Aetiological Concepts in Inflammatory Bowel Disease; R. Allan. 2. Pathophysiological Concepts of Inflammatory Bowel Disease; J.A. Katz, C. Fiocchi. 3. Alternative Concepts for the Aetiology and Pathogenesis of Inflammatory Bowel Disease; J. Rhodes, J.T. Green. Section II: Diagnostic Problems. 4. The Primary Diagnosis of Inflammatory Bowel Disease; S. Vermeire, et al. 5. Diagnostic Problems: Follow-up; M. Cottone, M. Rosselli. 6. Detection of Complications; C. Gasche. 7. New Diagnostic Tools in Investigation of IBD; H.J.F. Hodgson. Section III: State of the Art Lecture. 8. Diagnosis of Inflammatory Bowel Disease: Genetic and Therapeutic Implications of Sub-Stratification; T.M. Bayless, et al. Section IV: Definition of Patient Groups. 9. Definition of Patient Groups: Active Disease; M. Zeitz. 10. Refractory Disease; J. Brynskov. 11. Definition of Patient Groups: Remission; R. Modigliani. Section V: Special Problems of Patients with IBD. 12. Fertility and Pregnancy in Female Patients with Inflammatory Bowel Disease; G. Bianchi-Porro, et al. 13. Bone Metabolism in Inflammatory Bowel Disease; S. Ardizzone, et al. 15. Life Style Changes in Inflammatory Bowel Disease; E.J. Irvine. 16. Adverse Events of Medical Therapy for Treatment of Inflammatory Bowel Disease; R. Enns, L. Sutherland. Section VI: Drugs for the Treatment of IBD. 17. Steroids &endash; New and Old; V. Gross, et al. 18. The Use of Salicylate in Patients with Inflammatory Bowel Disease; M. Campieri, P. Gionchetti. 19. Immunosuppression in Inflammatory Bowel Disease; E.F. Stange. 20. Antibiotic Use in Crohn's Disease; C. Prantera, et al. Section VII: Surgical Treatment. 21. Surgery for Crohn's Disease; R.S. McLeod. 22. Ulcerative Colitis; M. Kettlewell. 23. Surgical Treatment of Anal Fistulae in Crohn's Disease; G. Hellers. Section VIII: State of the Art Lecture. 24. Prevention of Carcinoma; J.E. Lennard-Jones. Section IX: Supportive Treatment. 25. Diet and Nutrition; H. Lochs. 26. Special Problems of Patients with IBD &endash; Psychological Problems; G. Moser. 27. Micronutrients in Inflammatory Bowel Disease; C. Folwaczny. Section X: State of the Art Lecture. 28. State of the ART: Medical Management of Ulcerative Colitis; D.P. Jewell. Section XI: New Treatment Principles. 29. Omega-3 Fatty Acids and Inflammatory Bowel Disease; A. Belluzzi. 30. Cytokines and Anti-Cytokines in the Therapy of Inflammatory Bowel Disease; C.O. Elson, et al. 31. Gene Therapy; M. Cominelli. 32. Probiotics and Intestinal Flora; P. Gionchetti, et al. Section XII: State of the Art Lecture. 33. Treatment of Crohn's Disease; B.G. Feagan. Index.
